Search research articles
Contact Us
Filters
Showing results (111-120 of 190) with videos related to
Page
of 19
Sort By:
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Journal of Hypertension
|
October 7, 2005
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice
Karin Jandeleit-Dahm, Markus Lassila, Belinda J Davis, et al.
Free Radical Biology & Medicine
|
March 5, 2013
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
Karina Huynh, Helen Kiriazis, Xiao-Jun Du, et al.
Diabetologia
|
May 12, 2016
The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
Bryna S M Chow, Christine Koulis, Pooja Krishnaswamy, et al.
Diabetologia
|
June 22, 2019
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse
Jay C Jha, Aozhi Dai, Chet E Holterman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 2, 2013
Acamprosate produces its anti-relapse effects via calcium
Rainer Spanagel, Valentina Vengeliene, Bernd Jandeleit, et al.
Nature Reviews. Disease Primers
|
May 19, 2016
Diabetic kidney disease
Merlin C Thomas, Michael Brownlee, Katalin Susztak, et al.
Diabetologia
|
March 1, 2012
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K Huynh, H Kiriazis, X-J Du, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
G Soldatos, K Jandeleit-Dahm, H Thomson, et al.
Metabolites
|
June 2, 2021
Oral Supplementation of an Alkylglycerol Mix Comprising Different Alkyl Chains Effectively Modulates Multiple Endogenous Plasmalogen Species in Mice
Sudip Paul, Aliki A Rasmiena, Kevin Huynh, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 190) with videos related to
Sort By:
Page
of 19
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Journal of Hypertension
|
October 7, 2005
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice
Karin Jandeleit-Dahm, Markus Lassila, Belinda J Davis, et al.
Free Radical Biology & Medicine
|
March 5, 2013
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
Karina Huynh, Helen Kiriazis, Xiao-Jun Du, et al.
Diabetologia
|
May 12, 2016
The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
Bryna S M Chow, Christine Koulis, Pooja Krishnaswamy, et al.
Diabetologia
|
June 22, 2019
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse
Jay C Jha, Aozhi Dai, Chet E Holterman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 2, 2013
Acamprosate produces its anti-relapse effects via calcium
Rainer Spanagel, Valentina Vengeliene, Bernd Jandeleit, et al.
Nature Reviews. Disease Primers
|
May 19, 2016
Diabetic kidney disease
Merlin C Thomas, Michael Brownlee, Katalin Susztak, et al.
Diabetologia
|
March 1, 2012
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K Huynh, H Kiriazis, X-J Du, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
G Soldatos, K Jandeleit-Dahm, H Thomson, et al.
Metabolites
|
June 2, 2021
Oral Supplementation of an Alkylglycerol Mix Comprising Different Alkyl Chains Effectively Modulates Multiple Endogenous Plasmalogen Species in Mice
Sudip Paul, Aliki A Rasmiena, Kevin Huynh, et al.
Page
of 19